Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Resource Center: Rheumatoid Arthritis

By Rob Goodier NEW YORK (Reuters Health) – Biologic agents may be more effective than non-biologic drugs at improving physical function in rheumatoid arthritis patients, a new meta-analysis has found. In 35 studies with a total of 8733 treated...
ZURICH (Reuters) – Novartis said on Tuesday its arthritis drug canakinumab (Ilaris) was approved in the European Union to treat children aged two years and older with active systemic juvenile idiopathic arthritis (SJIA) who have responded...
By David Douglas NEW YORK (Reuters Health) – Seropositive rheumatoid arthritis (RA) patients show more profound changes in trabecular bone architecture than seronegative RA and psoriatic arthritis (PsA) patients, according to German and Austrian...